Market icon

Measles cases in U.S. by April 30?

Market icon

Measles cases in U.S. by April 30?

abr 30

dic 31

abr 30

dic 31

Polymarket

$62,960 Vol.

Polymarket

$62,960 Vol.

1800

$11,899 Vol.

93%

1900

$18,356 Vol.

72%

2000

$22,832 Vol.

41%

2100

$1,515 Vol.

13%

2200

$8,357 Vol.

11%

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of March 26, 2026, CDC data show 1,575 confirmed measles cases across 32 US jurisdictions this year, fueled by large outbreaks in South Carolina (over 600 cases), Texas, Utah, and others, mostly among unvaccinated children and adults in undervaccinated communities. This rapid escalation—surpassing 2025's early totals—reflects import-associated introductions from global hotspots amid declining MMR vaccination coverage below the 95% herd immunity threshold, enabling sustained person-to-person transmission via respiratory droplets. Epidemiological indicators signal high outbreak risk through spring; key variables include containment via contact tracing and vaccination campaigns. Traders track weekly CDC surveillance updates and state reports ahead of April 30 resolution, as new clusters could accelerate totals.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$62,960
Fecha de finalización
30 abr 2026
Mercado abierto
Mar 27, 2026, 1:49 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of March 26, 2026, CDC data show 1,575 confirmed measles cases across 32 US jurisdictions this year, fueled by large outbreaks in South Carolina (over 600 cases), Texas, Utah, and others, mostly among unvaccinated children and adults in undervaccinated communities. This rapid escalation—surpassing 2025's early totals—reflects import-associated introductions from global hotspots amid declining MMR vaccination coverage below the 95% herd immunity threshold, enabling sustained person-to-person transmission via respiratory droplets. Epidemiological indicators signal high outbreak risk through spring; key variables include containment via contact tracing and vaccination campaigns. Traders track weekly CDC surveillance updates and state reports ahead of April 30 resolution, as new clusters could accelerate totals.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$62,960
Fecha de finalización
30 abr 2026
Mercado abierto
Mar 27, 2026, 1:49 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

Cuidado con los enlaces externos.

Preguntas frecuentes

"Measles cases in U.S. by April 30?" es un mercado de predicción en Polymarket con 5 resultados posibles donde los operadores compran y venden acciones según lo que creen que sucederá. El resultado líder actual es "1800" con 93%, seguido de "1900" con 72%. Los precios reflejan probabilidades en tiempo real de la comunidad. Por ejemplo, una acción cotizada a 93¢ implica que el mercado colectivamente asigna una probabilidad de 93% a ese resultado. Estas probabilidades cambian continuamente a medida que los operadores reaccionan a nuevos desarrollos. Las acciones del resultado correcto son canjeables por $1 cada una tras la resolución del mercado.

A día de hoy, "Measles cases in U.S. by April 30?" ha generado $63K en volumen total de trading desde que el mercado se lanzó el Mar 24, 2026. Este nivel de actividad refleja un fuerte compromiso de la comunidad de Polymarket y ayuda a garantizar que las probabilidades actuales estén respaldadas por un amplio grupo de participantes del mercado. Puedes seguir los movimientos de precios en vivo y operar en cualquier resultado directamente en esta página.

Para operar en "Measles cases in U.S. by April 30?", explora los 5 resultados disponibles en esta página. Cada resultado muestra un precio actual que representa la probabilidad implícita del mercado. Para tomar una posición, selecciona el resultado que consideres más probable, elige "Sí" para operar a favor o "No" para operar en contra, introduce tu cantidad y haz clic en "Operar". Si tu resultado elegido es correcto cuando el mercado se resuelve, tus acciones de "Sí" pagan $1 cada una. Si es incorrecto, pagan $0. También puedes vender tus acciones en cualquier momento antes de la resolución.

El favorito actual para "Measles cases in U.S. by April 30?" es "1800" con 93%, lo que significa que el mercado asigna una probabilidad de 93% a ese resultado. El siguiente resultado más cercano es "1900" con 72%. Estas probabilidades se actualizan en tiempo real a medida que los operadores compran y venden acciones. Vuelve con frecuencia o guarda esta página en marcadores.

Las reglas de resolución para "Measles cases in U.S. by April 30?" definen exactamente qué debe ocurrir para que cada resultado sea declarado ganador, incluyendo las fuentes de datos oficiales utilizadas para determinar el resultado. Puedes revisar los criterios de resolución completos en la sección "Reglas" en esta página sobre los comentarios. Recomendamos leer las reglas cuidadosamente antes de operar, ya que especifican las condiciones exactas, casos especiales y fuentes.